Opportunity Information: Apply for RFA DP 11 003
Apply for RFA DP 11 003
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Epidemiologic Research and Surveillance in Epilepsy (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Feb 10, 2011 and posted on Dec 9, 2010.
- Applicants must submit their applications by Mar 4, 2011 On time submission requires that applications be successfully submitted to Grants.gov and validated no later than 500 p.m. eastern time on the deadline date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $450,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, released a discretionary funding opportunity titled "Epidemiologic Research and Surveillance in Epilepsy (U01)" under Funding Opportunity Number RFA-DP-11-003. This announcement supports public health work focused on epilepsy, specifically emphasizing epidemiologic research and surveillance activities designed to improve understanding of epilepsy at the population level. The award mechanism is a cooperative agreement (U01), which typically means recipients should expect substantial involvement from CDC staff in areas such as technical guidance, coordination, and programmatic collaboration, rather than a hands-off grant structure.
For fiscal year 2011, CDC anticipated making two awards with a total available funding amount of about $850,000. The maximum award amount (award ceiling) was listed as $450,000, while the award floor was stated as $0, indicating CDC did not specify a minimum award size. The funding falls under the Health activity category and is associated with CFDA number 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance). There was no cost sharing or matching requirement, so applicants were not required to provide non-federal matching funds as a condition of receiving an award.
Eligibility was described as unrestricted, meaning the opportunity was broadly open to many types of organizations and entities, subject to any additional eligibility language contained in the full announcement. Applications were required to be submitted through Grants.gov and successfully validated by 5:00 p.m. Eastern Time on the closing date. Key timeline dates included a posted date of December 9, 2010, a closing date of March 4, 2011 (also listed as the current closing date), and an archive date of April 3, 2011. The listing also notes an internal creation date of February 10, 2011. In practical terms, the most important compliance point for applicants was not only submitting by the deadline, but ensuring Grants.gov validation was completed by the deadline time as well.
The core purpose of the funding opportunity was to support epilepsy research and surveillance, meaning work that tracks and analyzes epilepsy-related health patterns, burden, outcomes, and related factors in populations. While the brief description does not list specific required projects or research questions, the title and purpose statement indicate that CDC sought to strengthen the evidence base for epilepsy through systematic data collection, analysis, and epidemiologic study. Cooperative agreement projects in this area commonly aim to improve estimates of prevalence and incidence, characterize disparities, monitor trends over time, or evaluate health and social impacts, depending on the program priorities described in the full FOA.
For applicants or interested parties who could not access the full announcement electronically, CDC provided support through its Procurement and Grants Office Technical Information and Management Section (TIMS). The contact phone number listed was 770-488-2700, with a general email contact referenced but not fully displayed in the excerpt provided.
Frequently Asked Questions (FAQs)
1) What is the title of this CDC funding opportunity?
The discretionary funding opportunity is titled "Epidemiologic Research and Surveillance in Epilepsy (U01)".
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA-DP-11-003.
3) Which agency is offering this opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office.
4) What is the purpose of the program?
The purpose is to support public health work focused on epilepsy, with an emphasis on epidemiologic research and surveillance designed to improve understanding of epilepsy at the population level.
5) What types of activities does "epidemiologic research and surveillance" imply?
Based on the description, activities generally involve tracking and analyzing epilepsy-related health patterns and outcomes in populations. This can include systematic data collection and analysis to strengthen the evidence base on epilepsy, such as estimating burden or monitoring patterns over time, depending on priorities described in the full announcement.
6) What is the award mechanism?
The award mechanism is a cooperative agreement (U01).
7) What does a U01 cooperative agreement mean for recipients?
A cooperative agreement (U01) typically means recipients should expect substantial involvement from CDC staff in areas like technical guidance, coordination, and programmatic collaboration, rather than a hands-off grant structure.
8) How many awards did CDC anticipate making?
For fiscal year 2011, CDC anticipated making two (2) awards.
9) What was the total estimated funding amount available?
The total available funding amount was approximately $850,000 for fiscal year 2011.
10) What was the maximum award amount (award ceiling)?
The award ceiling was listed as $450,000.
11) Was there a minimum award amount (award floor)?
The award floor was stated as $0, meaning CDC did not specify a minimum award size.
12) What activity category does this opportunity fall under?
The funding falls under the Health activity category.
13) What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance).
14) Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement, so applicants were not required to provide non-federal matching funds as a condition of receiving an award.
15) Who is eligible to apply?
Eligibility was described as unrestricted, meaning it was broadly open to many types of organizations and entities, subject to any additional eligibility language in the full announcement.
16) How were applications required to be submitted?
Applications were required to be submitted through Grants.gov.
17) What does "successfully validated" on Grants.gov mean in this listing?
The listing emphasizes that it was not enough to submit by the deadline. The application needed to be successfully validated in Grants.gov by the stated deadline time on the closing date.
18) What was the deadline to submit and validate the application?
Applications had to be submitted through Grants.gov and successfully validated by 5:00 p.m. Eastern Time on the closing date.
19) What was the posted date for this opportunity?
The posted date was December 9, 2010.
20) What was the closing date?
The closing date listed was March 4, 2011 (also noted as the current closing date).
21) What was the archive date?
The archive date listed was April 3, 2011.
22) What internal date is mentioned in the listing?
The listing notes an internal creation date of February 10, 2011.
23) What is the most important timing/compliance point highlighted for applicants?
The key compliance point highlighted is that applicants needed to ensure Grants.gov validation was completed by the deadline time (not just that the application was submitted).
24) Does the brief description list specific required projects or research questions?
No. The excerpt does not list specific required projects or research questions. It indicates a general focus on strengthening the evidence base for epilepsy through research and surveillance.
25) What kinds of outcomes or topics might be addressed under this type of cooperative agreement (based on the excerpt)?
The excerpt suggests a population-level focus such as improving understanding of epilepsy burden and patterns. Examples mentioned as common aims in this area include improving estimates of prevalence and incidence, characterizing disparities, monitoring trends over time, and evaluating health and social impacts, depending on what is described in the full FOA.
26) Where could applicants get help if they could not access the full announcement electronically?
CDC offered support through the Procurement and Grants Office Technical Information and Management Section (TIMS).
27) What contact phone number is provided for TIMS support?
The contact phone number listed is 770-488-2700.
28) Is an email contact provided?
The excerpt references a general email contact, but it is not fully displayed in the information provided.
Browse more opportunities from the same category: Health
Next opportunity: Public Health Research for the Prevention of Complications of Bleeding Disorders
Previous opportunity: Chronic Illness Self Management in Children and Adolescents (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DP 11 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DP 11 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Public Health Research for the Prevention of Complications of Bleeding Disorders Apply for RFA DD 11 009 Funding Number: RFA DD 11 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| The Association of Genetic Biomarkers and Hereditary Hemochromatosis (U01) Apply for RFA DD 11 008 Funding Number: RFA DD 11 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellowships in Muscular Dystrophy Research (F32) Apply for PA 11 075 Funding Number: PA 11 075 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Informatics Tools for High Throughput Sequence Data Analysis (SBIR) (R43/R44) Apply for RFA HG 10 019 Funding Number: RFA HG 10 019 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Informatics Tools for High Throughput Sequence Data Analysis (U01) Apply for RFA HG 10 018 Funding Number: RFA HG 10 018 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Research Activities In Support Of Malaria Prevention and Control in the Republic Of Uganda As Part of the President s Malaria Initiative Apply for RFA GH 11 004 Funding Number: RFA GH 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Pilot for State specific Cross Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes Apply for RFA DD 11 004 Funding Number: RFA DD 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Mendelian Disorders Genome Centers (U54) Apply for RFA HG 10 016 Funding Number: RFA HG 10 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genome Sequencing and Analysis Centers (U54) Apply for RFA HG 10 015 Funding Number: RFA HG 10 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Muscular Dystrophy Surveillance Tracking and Research Network MD STARnet Feasibility of Expansion to other Muscular Dystrophies Apply for RFA DD 11 006 Funding Number: RFA DD 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Limited Competition for the Renewal of the National Cell Repository for Alzheimers Disease (NCRAD) (U24) Apply for PAR 11 080 Funding Number: PAR 11 080 Agency: National Institutes of Health Category: Health Funding Amount: $675,000 |
| Expanding Maternal and Neonatal Survival (EMAS) Apply for RFA 497 11 000002 Funding Number: RFA 497 11 000002 Agency: Indonesia USAID Jakarta Category: Health Funding Amount: $55,000,000 |
| HIV Prevention with Youth and Adults Program in Lesotho Apply for 674 11 0004 Funding Number: 674 11 0004 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $17,000,000 |
| Clinical Sequencing Exploratory Research (U01) Apply for RFA HG 10 017 Funding Number: RFA HG 10 017 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Development of a Preliminary Evidence Base to Inform Decision making about Returning Research Results to Participants in Genomic Studies (R01) Apply for RFA HG 11 003 Funding Number: RFA HG 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Ethical, Legal, and Social Implications of Returning Research Results to Genomic Research Participants (R21) Apply for RFA HG 11 004 Funding Number: RFA HG 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Long Term MCH Training LEND Apply for HRSA 11 036 Funding Number: HRSA 11 036 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Disparities in Perinatal Health Border, Alaska and Hawaii Apply for HRSA 11 018 Funding Number: HRSA 11 018 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Improving Access to Hearing Health Care (STTR) R41/R42 Apply for RFA DC 12 002 Funding Number: RFA DC 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Access to Hearing Health Care (SBIR) R43/R44 Apply for RFA DC 12 001 Funding Number: RFA DC 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DP 11 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.